Literature DB >> 18577497

Macular function surveillance revisited.

Richard Trevino1, Michael G Kynn.   

Abstract

BACKGROUND: The Amsler grid is a widely used means of evaluating the central 20 degrees diameter visual field. It is a common practice to have patients who are at risk for exudative maculopathy evaluate their macular function daily using the Amsler grid. The goal is to make the patient aware of the earliest symptoms of choroidal neovascularization at a time when therapeutic intervention has the greatest chance for success. There are, however, several important shortcomings of self-monitoring macular function with the Amsler grid, including low sensitivity and low compliance.
METHODS: The history of macular function surveillance is reviewed. The following techniques that are either currently available or under development for home self-monitoring of macular function are discussed: Amsler grid, red Amsler grid, threshold Amsler grid, environmental Amsler techniques, entoptic perimetry, preferential hyperacuity perimetry, and Internet-based interventions.
CONCLUSION: There is compelling evidence that several currently available technologies are superior to the conventional Amsler grid in detecting the earliest symptoms of macular disease. Threshold Amsler grid, entoptic perimetry, and preferential hyperacuity perimetry each have been found to be more sensitive than the conventional Amsler grid in detecting vision disturbances caused by macular disease. Any one of these diagnostic tests could conceivably be utilized by patients at home for self-monitoring of macular function if the technology were suitably deployed for this purpose, such as over the Internet.

Entities:  

Mesh:

Year:  2008        PMID: 18577497     DOI: 10.1016/j.optm.2007.09.017

Source DB:  PubMed          Journal:  Optometry        ISSN: 1558-1527


  6 in total

1.  The accuracy of home monitoring to detect disease activity during maintenance therapy for neovascular ARMD.

Authors:  Martin McKibbin; Lucy Baker; Paul Baxter; Carolyn Czoski-Muray; Roopa Setty
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-11-05       Impact factor: 3.117

2.  Environmental Amsler test as a monitoring tool for retreatment with ranibizumab for neovascular age-related macular degeneration.

Authors:  R Mathew; S Sivaprasad
Journal:  Eye (Lond)       Date:  2011-12-16       Impact factor: 3.775

3.  Randomized trial of a home monitoring system for early detection of choroidal neovascularization home monitoring of the Eye (HOME) study.

Authors:  Emily Y Chew; Traci E Clemons; Susan B Bressler; Michael J Elman; Ronald P Danis; Amitha Domalpally; Jeffrey S Heier; Judy E Kim; Richard Garfinkel
Journal:  Ophthalmology       Date:  2013-11-08       Impact factor: 12.079

Review 4.  Strategies for improving early detection and diagnosis of neovascular age-related macular degeneration.

Authors:  Pearse A Keane; Gabriella de Salvo; Dawn A Sim; Srini Goverdhan; Rupesh Agrawal; Adnan Tufail
Journal:  Clin Ophthalmol       Date:  2015-02-17

5.  Presymptomatic Retinal Sensitivity Changes in Intermediate Age-Related Macular Degeneration Associated With New Retinal Fluid.

Authors:  Antony J Wightman; Carla J Abbott; Myra B McGuinness; Emily Caruso; Robyn H Guymer; Chi D Luu
Journal:  Transl Vis Sci Technol       Date:  2019-11-12       Impact factor: 3.283

Review 6.  Lutein, Zeaxanthin and Meso-zeaxanthin Supplementation Associated with Macular Pigment Optical Density.

Authors:  Le Ma; Rong Liu; Jun Hui Du; Tao Liu; Shan Shan Wu; Xiao Hong Liu
Journal:  Nutrients       Date:  2016-07-12       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.